Tobacco kills 8 million people worldwide every year, but imagine if it could be used to make medicine. The idea isn't unheard ...

Medicago’s CEO. “Our proven plant-based technology is capable of contributing to the collective solution to this public health emergency,” he added. One of the lead vaccine candidates ...

That holds doubly true for Medicago, a Canadian biopharma company. Medicago uses plants to produce vaccine and therapeutic candidates, and the platform has found new purpose in the age of coronavirus.

So Medicago, a clinical-stage biopharmaceutical company located in Quebec, Canada, is harnessing a plant-based transient expression process to produce pharmaceutical-grade proteins in a matter of ...

Japanese pharmaceutical giant Mitsubishi Tanabe Pharma Corp. announced that a COVID-19 vaccine derived from a type of tobacco plant and developed by Medicago Inc., the Osaka-based company’s ...

We can hijack this process to give plants genetic instructions for new proteins. Canadian company Medicago has produced a candidate covid-19 vaccine using this method. Within 20 days of obtaining ...